跳至主要内容
临床试验/NCT01536275
NCT01536275进行中(未招募)不适用

Impact of Early Parenteral Nutrition Completing Enteral Nutrition in Paediatric Critically Ill Patients

KU Leuven6 个研究点 分布在 3 个国家目标入组 1,440 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
KU Leuven
入组人数
1,440
试验地点
6
主要终点
Incidence of new infection during ICU stay

研究概览

简要总结

In the PEPaNIC trial it is investigated whether withholding parenteral nutrition during the first week in critically ill children is beneficial, compared to the current standard of the early start of parenteral nutrition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
— 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • All patients admitted to the PICU with a STRONGkids score of 2 points or more upon ICU admission

排除标准

  • Age of 17 years or older
  • Patients with a DNR code at the time of ICU admission.
  • Patients expected to die within 12 hours (=moribund patients).
  • Patient readmitted to ICU after randomization to the PEPaNIC trial, more than 48 hours after the initial discharge
  • Patients transferred from another paediatric intensive care after a stay of more than 7 days
  • Patients suffering from ketoacidotic or hyperosmolar coma on admission.
  • Patients suffering from Short Bowel Syndrome on home PN or other conditions that require home PN
  • Patients suspicious or established inborn metabolic diseases requiring specific diet
  • STRONGkids score lower than 2 on ICU admission.
  • Premature Newborns ( 37 weeks gestational age upon admission in the PICU)
  • Prior inclusion in another randomized controlled outcome study

结局指标

主要结局

Incidence of new infection during ICU stay

时间窗: during ICU stay and up to 90 days post-randomization

Duration of ICU dependency (crude stay days and time to alive discharge from ICU)

时间窗: during ICU stay and up to 90 days post-randomization

次要结局

  • Mortality(during ICU stay, hospital stay and up to 90 days post-randomization)
  • Incidence of hypoglycaemia during ICU stay(during the intervention window up to day 8 post-randomization)
  • Incidence of liver dysfunction during ICU stay(during ICU stay and up 90 days post-randomization)
  • Need for haemodynamic support during ICU stay(during ICU stay and up 90 days post-randomization)
  • Incidence of new kidney injury during ICU stay(during ICU stay and up 90 days post-randomization)
  • Number of readmissions to the ICU(up to 90 days post-randomization)
  • health economy analysis(during index hospitalization)
  • Time to alive discharge from hospital(during hospital stay and up to 90 days post-randomization)
  • Time to final weaning from mechanical respiratory support(during ICU stay and up to 90 days post-randomization)
  • Duration of antibiotics treatment during ICU stay(during ICU stay and up to 90 days post-randomization)
  • Amount of calories delivered during the ICU stay and in subset markers of feeding intolerance(during the intervention window of 8 days and up to 90 days post-randomization)
  • Structural and or functional differences in muscle tissue during ICU stay(during ICU stay and up to 90 days post-randomization)
  • biochemical, metabolic, endocrine, immunological, inflammatory and (epi)genetic markers on blood samples(up to 4 years post-randomization)
  • functional and neurocognitive development(up to 4 years post-randomization)
  • Markers of inflammation such as C-reactive protein concentrations during ICU stay(during ICU stay and up to 90 days post-randomization)

研究者

发起方
KU Leuven
申办方类型
Other
责任方
Principal Investigator
主要研究者

Greet Van den Berghe

Head of Dept Intensive Care Medicine

KU Leuven

研究点 (6)

Loading locations...

相似试验